CMD Bioscience's Seed VC Round

CMD Bioscience raised a round of funding on February 14, 2011. Investors include Connecticut Innovations.

CMD Bioscience operates drug design (CADD) software that enables peptide-based drug discovery. The core business model is to employ methods to design peptides for key protein targets and then seek pep…

Articles about CMD Bioscience's Seed VC Round: